Inhalant dependence with inhalant-induced psychotic disorder with hallucinations
ICD-10 F18.251 is a billable code used to indicate a diagnosis of inhalant dependence with inhalant-induced psychotic disorder with hallucinations.
F18.251 refers to a condition characterized by a dependence on inhalants, which are substances that produce chemical vapors that can be inhaled to induce psychoactive effects. This code specifically denotes the presence of inhalant-induced psychotic disorder, which manifests as hallucinations. Patients with this condition may experience significant impairment in social, occupational, or other important areas of functioning due to their substance use. The inhalants can include a variety of substances such as glue, paint thinners, and nitrous oxide. The psychotic symptoms can include visual or auditory hallucinations, delusions, and disorganized thinking. Treatment typically involves a combination of detoxification, counseling, and support groups, as well as addressing any co-occurring mental health disorders. The chronic use of inhalants can lead to severe health complications, including neurological damage, which necessitates a comprehensive treatment approach.
Comprehensive mental health evaluations, including history of substance use and current symptoms.
Patients presenting with acute psychosis following inhalant use, or chronic users seeking help for dependence.
Ensure thorough documentation of both substance use history and mental status examinations.
Detailed treatment plans, including detoxification protocols and follow-up care.
Patients undergoing rehabilitation for inhalant dependence with co-occurring mental health issues.
Documenting the multidisciplinary approach to treatment, including counseling and support services.
Used when assessing a patient with inhalant dependence and psychotic symptoms.
Detailed mental health evaluation notes.
Psychiatric evaluations must include substance use history.
Symptoms include hallucinations, delusions, and disorganized thinking, which arise during or shortly after inhalant use.
